NASDAQ:CLLS - Cellectis S.A.
$15.41
 $0.18
+1.18%
11:10AM EDT
2019-07-22
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. The Company also offers rational inverse genetics and targeting recombination tools. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CLLS     avg for
industry  
  avg for
sector  
42 stocks weight:  26. 44   217. 37   399. 45  
42 stocks rank:  2. 96 K 1. 27 K 716. 99  
# analyst opinions:  9. 00   13. 21   13. 71  
mean recommendation:  1. 80   2. 10   2. 04  

quick ratio:  9. 47   5. 49   1. 88  
current ratio:  9. 77   5. 87   2. 36  

target price low:  21. 00   83. 44   114. 90  
target price avg:  41. 00   106. 20   137. 90  
target price high:  23. 24   132. 30   158. 97  
1-yr high:  30. 34   111. 86   142. 57  
last close:  15. 23   86. 79   125. 44  
50-day avg:  16. 28   86. 68   122. 63  
200-day avg:  19. 30   89. 22   121. 38  
1-yr low:  14. 60   69. 78   100. 51  
volume:  52. 09 K 2. 62 M 3. 43 M
50-day avg volume:  119. 15 K 3. 20 M 4. 16 M
200-day avg volume:  132. 25 K 2. 99 M 4. 75 M

1-day return:  -0. 13 % -1. 30 % -0. 99 %
this week return:  -5. 87 % 0. 45 % -0. 20 %
12-wk return:  -23. 04 % 0. 94 % 4. 84 %
52-wk return:  -49. 74 % -1. 30 % 10. 55 %

enterprise value (EV):  301. 56 M 45. 10 B 122. 38 B
market cap:  644. 80 M 38. 96 B 108. 40 B
EBITDA:  -101. 72 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -2. 96   5. 38   11. 93  
enterprise/revenue (EV/R):  17. 95   57. 92   10. 21  
total revenue:  16. 80 M 9. 91 B 39. 98 B
total debt:  35. 65 M 10. 90 B 17. 48 B
debt/equity:  8. 25   57. 18   120. 05  
net income (common):  -68. 50 M 2. 07 B 4. 05 B

shares outstanding:  35. 93 M 538. 09 M 1. 24 B
shares:  28. 06 M 548. 00 M 1. 22 B
shares short:  331. 94 K 10. 98 M 11. 87 M
shares short prior month:  192. 45 K 9. 32 M 12. 05 M
short ratio:  2. 08   5. 60   3. 34  
total cash/share:  9. 93   10. 98   9. 19  
total cash:  421. 46 M 5. 93 B 6. 10 B
free cash flow:  -45. 87 M 2. 92 B 4. 55 B
operating cash flow:  -70. 56 M 3. 80 B 5. 78 B

book value:  9. 22   13. 35   27. 45  
price/book:  1. 65   4. 60   8. 78  
gross profits:  18. 69 M 7. 44 B 36. 13 B
operating margins:  -618. 40 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  83. 65 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 62   2. 10   4. 23  
forward EPS:  -2. 31   3. 45   7. 10  
P/E:  -9. 42   1. 90   32. 10  
forward P/E:  -6. 59   6. 46   15. 47  
PE/G:  0. 16   0. 70   -0. 54  
growth:  -57. 50 % 265. 63 % 79. 11 %
earnings high:  -0. 48   0. 89   1. 68  
earnings avg:  -0. 60   0. 70   1. 57  
earnings low:  -0. 76   0. 46   1. 46  
revenue high:  8. 00 M 2. 57 B 11. 07 B
revenue avg:  3. 85 M 2. 51 B 10. 91 B
revenue low:  510. 00 K 2. 45 B 10. 73 B
return on assets:  -15. 53 % -2. 34 % 5. 28 %
return on equity:  -22. 29 % -90. 08 % 133. 53 %
revenue growth:  -57. 50 % 265. 25 % 73. 68 %
revenue/share:  0. 40   12. 72   60. 04  

beta (1yr vs S&P500):  1. 38   1. 27   0. 91  
sharpe (1yr):  -1. 42   0. 16   0. 77  

held % insiders:  0. 00 % 6. 06 % 3. 29 %
held % institutions:  30. 16 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CLLS
.    120.963 =       120.963 :: --> INITIAL WEIGHT <--
.    - 1.617 =       119.346 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.246 =       268.092 :: P/E factor
.    x 1.572 =       421.409 :: PE/G factor
.    x 1.584 =       667.401 :: beta factor
.    x 0.818 =         545.8 :: sharpe factor
.    x 2.336 =       1274.74 :: current ratio factor
.    x 1.057 =        1347.9 :: quick ratio factor
.    x 1.217 =      1640.217 :: short ratio factor
.     x 1.31 =      2148.556 :: EV/R factor
.    x 1.008 =      2166.231 :: price-to-book factor
.    x 0.808 =      1749.992 :: debt-to-revenue factor
.     x 1.07 =      1871.924 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      3969.964 :: sector+industry 1-year gains factor
.    x 1.009 =      4007.393 :: industry 12-weeks return factor
.    x 1.308 =      5241.224 :: industry 2-weeks return factor
.    x 0.889 =       4659.92 :: company one-year gains+dividend factor
.    x 2.098 =       9776.53 :: company 13 weeks' performance factor
.    x 0.983 =      9606.753 :: "drift" penalty 1 days ago
.    / 1.917 =      5010.788 :: overall "drift" factor
.    x 0.914 =      4579.845 :: largest single-day jump factor
.    x 0.513 =      2348.639 :: low price factor
.    x 1.168 =      2744.302 :: notable returns + performance factor
.    x 3.612 =      9911.439 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.766 =      7592.685 :: forward EPS factor
.    x 0.915 =      6947.218 :: forward P/E factor
.    x 1.185 =      8230.456 :: industry recommendation factor
.    x 2.554 =     21019.995 :: company recommendation factor
.    x 1.003 =     21078.123 :: factor historical industry gain for week 29
.   x 10.953 =    230862.449 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         21.92 :: reduced for readability
.    + 4.525 =        26.444 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     26.444 :: FINAL WEIGHT for NASDAQ:CLLS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org